Hemorrhage is uncommon in new Alzheimer family with Flemish amyloid precursor protein mutation

Neurology

Volumn 63, Issue 9, 2004, Pages 1613-1617

  Brooks, W S ^a,d,f   Kwok, J B J ^b   Halliday, G M ^a   Godbolt, A K ^c   Rossor, M N ^c   Creasey, H ^d   Jones, A O ^e   Schofield, P R ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF SYDNEY   (Australia)

^e BLACKTOWN HOSPITAL   (Australia)

^f NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; DNA;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CLINICAL FEATURE; DOMINANT INHERITANCE; FAMILIAL DISEASE; FAMILY HISTORY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; MALE; MEDICAL RECORD; NEUROPATHOLOGY; PEDIGREE ANALYSIS; PRESENILE DEMENTIA; PRIORITY JOURNAL; VASCULAR AMYLOIDOSIS; VASCULAR DISEASE;

EID: 8644275574     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000142965.10778.C7     Document Type: Article

References (22)

1. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-706.
2. Levy E, Carman MD, Fernandez-Madrid IJ, et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990;248:1124-1126.
3. Van Broeckhoven C, Haan J, Bakker E, et al. Amyloid β protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science 1990;248:1120-1122.
4. Bakker E, Van Broeckhoven C, Haan J, et al. DNA diagnosis for hereditary cerebral hemorrhage with amyloidosis (Dutch type). Am J Hum Genet 1991;49:518-521.
5. Bugiani O, Padovani A, Magoni M, et al. An Italian type of HCHWA. Neurobiol Aging 1998;19:S238. Abstract.
6. Nilsberth C, Westlind-Danielsson A, Eckman CB, et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation. Nat Neurosci 2001;4:887-893.
7. Grabowski TJ, Cho HS, Vonsattel JPG, Rebeck GW, Greenberg SM. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 2001;49:697-705.
8. Iglesias S, Chapon F, Baron JC. Familial occipital calcifications, hemorrhagic strokes, leukoencephalopathy, dementia, and external carotid dysplasia. Neurology 2000;55:1661-1667.
9. Hendriks L, van Duijn CM, Cras P, et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nat Genet 1992;1:218-221.
10. Cras P, van Harskamp F, Hendriks L, et al. Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala→Gly mutation. Acta Neuropathol 1998;96:253-260.
11. Roks G, van Harskamp F, De Koning I, et al. Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692). Brain 2000;123:2130-2140.
12. Kwok J, Taddei K, Hallupp M, et al. Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. NeuroReport 1997;8:1537-1542.
13. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha1. J Lipid Res 1990;31:545-548.
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
15. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
16. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
17. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
18. National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18(suppl 4):S1-2.
19. Kumar-Singh S, Cras P, Wang R, et al. Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric. Am J Pathol 2002;161:507-520.
20. Haan J, Van Broeckhoven C, van Duijn CM, et al. The apolipoprotein E ε4 allele does not influence the clinical expression of the amyloid precursor protein gene codon 692 or 693 mutations. Ann Neurol 1994;36:434-437.
21. Halliday G, Brooks W, Arthur H, Creasey H, Broe GA. Further evidence for an association between a mutation in the APP gene and Lewy body formation. Neurosci Lett 1997;227:49-52.
22. van Harskamp F, Cras P, Hendriks L, et al. A family with early-onset Alzheimer's disease and cerebral haemorrhage due to a mutation (codon 692) in the β-amyloid precursor protein gene. In: Iqbal K, Winblad B, Nishimura T, Takeda M, Wisniewski HM, eds. Alzheimer's disease: biology, diagnosis and therapeutics. Chichester: John Wiley, 1997;155-159.